Cargando…

Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010503/ https://www.ncbi.nlm.nih.gov/pubmed/33592531 http://dx.doi.org/10.1016/j.thromres.2021.01.023

Ejemplares similares

Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’
por: Hardy, M., et al.
Publicado: (2022)

Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era
por: Qin, Wei, et al.
Publicado: (2021)

Pulmonary embolism in a young pregnant woman with COVID-19
por: Martinelli, Ida, et al.
Publicado: (2020)

Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome
por: Scudiero, Fernando, et al.
Publicado: (2021)

Three-month follow-up of pulmonary embolism in patients with COVID-19
por: Whyte, Martin B., et al.
Publicado: (2021)

Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2021)

Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
por: Lawlor, Matthew, et al.
Publicado: (2021)

Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study
por: Hardy, M., et al.
Publicado: (2023)

Association between Covid-19 and Pulmonary Embolism (AC-19-PE study)
por: Miró, Òscar, et al.
Publicado: (2020)

Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19
por: Vitali, Claudio, et al.
Publicado: (2020)

Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
por: Catella, Judith, et al.
Publicado: (2022)

More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism
por: van Dam, L.F., et al.
Publicado: (2020)

Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
por: Preti, Paola S., et al.
Publicado: (2021)

Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020)

Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients
por: Tsolaki, Vasiliki, et al.
Publicado: (2020)

Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic
por: Husser, Daniela, et al.
Publicado: (2021)

Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department
por: Luu, Inge H.Y., et al.
Publicado: (2021)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients
por: Speksnijder, Esther M., et al.
Publicado: (2022)

Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation
por: Parry, Arshed Hussain, et al.
Publicado: (2020)

Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group
por: Ray, Joel G., et al.
Publicado: (2021)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
por: Moll, Matthew, et al.
Publicado: (2021)

Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors()
por: Nauka, Peter C., et al.
Publicado: (2021)

D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19
por: Stawiarski, Kristin, et al.
Publicado: (2021)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

The reversed halo sign: Considerations in the context of the COVID-19 pandemic
por: Marchiori, Edson, et al.
Publicado: (2020)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
por: Choi, Justin J., et al.
Publicado: (2020)

Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome
por: Seaman, Craig D., et al.
Publicado: (2020)

Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization
por: Rajendram, Rajkumar, et al.
Publicado: (2020)

Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
por: Godon, Alexandre, et al.
Publicado: (2021)

Pulmonary Embolism and Increased Levels of D-Dimer in Patients with Coronavirus Disease
por: Chan, Kok Hoe, et al.
Publicado: (2020)

Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism
por: Surgit, Ozgur, et al.
Publicado: (2023)

COVID-19 associated pulmonary thrombosis
por: van Nieuwkoop, C.
Publicado: (2020)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Role of upfront CT pulmonary angiography at admission in COVID-19 patients
por: Jalaber, Carole, et al.
Publicado: (2020)

In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis
por: Mandal, Amit K.J., et al.
Publicado: (2021)

In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist
por: Wang, Lan, et al.
Publicado: (2020)

Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study
por: Hardy, Michaël, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kmme7q9mvuc6otcv4fa56gcb03